vak694
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00929968)
Timeline
Indications
Mechanism of action
- Interleukin-13INHIBITOR
IL13 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- vak694
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01568762 | Phase 1 | Oct 1, 2010 | Novartis |
| NCT01018693 | Phase 2 | Nov 1, 2009 | Novartis |
| NCT00929968 | Phase 2 | Jun 1, 2009 | Novartis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 3 | 3 | 2 | 2009 |
1 organizations
Page 1 / 1